Western blot analysis for selected EV biomarkers revealed that CD63, TSG101, TAPA1, and Alix were present in NPC-EVs obtained from both PEG enrichment and ultracentrifugation only (Fig. 1a, b). The gene discussed is CD63; the disease is nasopharyngeal carcinoma.